[{"Assets_0_Q2_USD":130409000.0,"CommonStockSharesOutstanding_0_Q2_shares":20289907.0,"EarningsPerShareBasic_1_Q2_USD":-0.13,"EarningsPerShareBasic_2_Q2_USD":-0.79,"EarningsPerShareDiluted_1_Q2_USD":-0.13,"EarningsPerShareDiluted_2_Q2_USD":-0.79,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-10740000.0,"NetIncomeLoss_1_Q2_USD":-2684000.0,"NetIncomeLoss_2_Q2_USD":-14119000.0,"StockholdersEquity_0_Q2_USD":109175000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":20271000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":17797000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":20271000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":17797000.0,"Ticker":"ANAB","CIK":"1370053","name":"ANAPTYSBIO INC","OfficialName":"AnaptysBio Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"617648593.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170810"}]